Therapeutic Strategies Including Avastin as 1st Line Therapy in Elderly Patients Suffering From Advanced (IIIB/IV Stage) Non-squamous Non-small Cell Lung Cancer, in Routine Clinical Practice
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 08 Sep 2017
At a glance
- Drugs Bevacizumab (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors Roche
- 01 Sep 2017 Planned End Date changed from 1 Jun 2017 to 6 Oct 2017.
- 01 Nov 2016 Status changed from recruiting to active, no longer recruiting.
- 03 Oct 2016 Status changed from active, no longer recruiting to recruiting.